Branching Out

Lately, the pharma sector in India is focusing on OTC products besides working on its usual fare. A move that could be win-win for both businesses and consumers

Is It The End Of Pharma’s Dream Run?

Unless the Indian pharma industry — not long ago touted as the pharmacy of the world — strives to be more than just a plain generics player

BP, Cardiac Drug In Short Supply

Drug makers blame price controls over the short supply of the drug. Mankind Pharmaceuticals stopped manufacturing the drug as soon as the price control was announced. The company says they paid taxes out of their own pocket due to nonviable costing

ChrysCapital Sells 11% Stake In Mankind Pharma For $200 Mn

Home-grown private equity giant ChrysCapital has sold its existing 11 per cent stake in Delhi-based Mankind Pharma to Capital International Private Equity Fund for $200 million in a secondary transaction.

Leveraging Technology As Psychometric Tool Is A Great Hiring Trend, Says Pradip P. Sachdeva of Mankind Pharma

Testing Times For Mankind Pharma